Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APLS | IBRX | ALKS | ||
| Company | Apellis Pharmaceuticals Inc | Immunitybio Inc | Alkermes Plc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 35.75 | 6.17 | 24.26 | ||
| High | 36.59 | 6.38 | 24.45 | ||
| Low | 35.10 | 6.14 | 24.14 | ||
| Last | 36.24 | 6.36 | 24.29 | ||
| Change | +0.83 | +0.08 | +0.06 | ||
| % Change | +2.34% | +1.27% | +0.25% | ||
| Volume | 1,232,900 | 1,294,300 | 789,400 | ||
| 20-Day Average Volume | 1,381,490 | 3,852,325 | 1,904,260 | ||
| Previous Close | 35.41 | 6.28 | 24.23 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 39.66 | 6.35 | 24.48 | ||
| 20-Day Raw Stochastic | 17.09% | 40.65% | 43.81% | ||
| 20-Day Relative Strength | 38.13% | 48.43% | 48.28% | ||
| Weighted Alpha | -38.63 | -22.43 | -18.44 | ||
| Today's Opinion | 100% Sell | 56% Buy | 56% Sell | ||
| Previous Opinion | 100% Sell | 40% Buy | 72% Sell | ||
| Last Month's Opinion | 88% Sell | 64% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -12.72% since 06/27/24 | -2.75% since 06/27/24 | unch since 06/27/24 | ||
| Low | 34.69 on 07/02/24 | 6.01 on 07/02/24 | 23.92 on 06/28/24 | ||
| High | 39.65 on 06/28/24 | 6.65 on 07/01/24 | 24.66 on 07/01/24 | ||
| 1-Month | |||||
| %Chg | -12.67% since 06/05/24 | unch since 06/05/24 | +0.41% since 06/05/24 | ||
| Low | 34.69 on 07/02/24 | 5.49 on 06/12/24 | 23.37 on 06/10/24 | ||
| High | 43.76 on 06/12/24 | 7.63 on 06/24/24 | 25.47 on 06/12/24 | ||
| 3-Month | |||||
| %Chg | -35.18% since 04/05/24 | +11.38% since 04/05/24 | -7.01% since 04/05/24 | ||
| Low | 34.69 on 07/02/24 | 4.73 on 04/12/24 | 23.14 on 05/29/24 | ||
| High | 57.85 on 04/11/24 | 10.53 on 04/29/24 | 27.56 on 04/09/24 | ||
| 6-Month | |||||
| %Chg | -39.20% since 01/05/24 | +44.22% since 01/05/24 | -14.95% since 01/05/24 | ||
| Low | 34.69 on 07/02/24 | 3.12 on 01/25/24 | 23.14 on 05/29/24 | ||
| High | 73.80 on 01/09/24 | 10.53 on 04/29/24 | 32.88 on 02/16/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,297,570 | 4,343,047 | 4,100,225 | ||
| Shares Outstanding, K | 121,366 | 691,568 | 169,221 | ||
| Annual Sales | 396,590,000 | 620,000 | 1,663,410,000 | ||
| Annual Net Income | -528,630,000 | -583,200,000 | 355,760,000 | ||
| Last Quarter Sales | 172,330,000 | 40,000 | 350,370,000 | ||
| Last Quarter Net Income | -66,420,000 | -134,110,000 | 36,830,000 | ||
| 60-Month Beta | 0.88 | 1.07 | 0.47 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.54 on 05/07/24 | -0.20 on 05/09/24 | 0.44 on 05/01/24 | ||
| Latest Earnings Date | 07/29/24 | 08/13/24 | 07/24/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 16.02 | ||